Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Association of non-alcoholic s...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR
Bibliographic Details
Main Authors:
Bethel, A
,
Califf, R
,
McMurray, J
,
Labed, A
,
Holman, R
,
Haffner, S
Format:
Conference item
Published:
2005
Holdings
Description
Similar Items
Staff View
Similar Items
Determining the most appropriate components for a composite clinical trial outcome.
by: Bethel, M, et al.
Published: (2008)
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
by: Califf, R, et al.
Published: (2008)
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
by: McMurray, J, et al.
Published: (2012)
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
by: Bethel, M, et al.
Published: (2009)
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
by: Mcmurray, J, et al.
Published: (2012)